• Home/
  • Publications/
  • i/
  • item/
  • AZD1222 vaccine against COVID-19 developed by Oxford University and Astra Zeneca: Background paper (draft)

AZD1222 vaccine against COVID-19 developed by Oxford University and Astra Zeneca: Background paper (draft)

10 February 2021
 | COVID-19: Critical preparedness, readiness and response
AZD1222 vaccine against COVID-19 developed by Oxford University and Astra Zeneca: Background paper (draft)
Download (1.1 MB)

Overview

This document provides the background evidence related to the Interim recommendations for use of the AZD1222 (ChAdOx1-S [recombinant]) vaccine against COVID-19 developed by Oxford University and AstraZeneca

Related document:

Interim recommendations for use of the AZD1222 (ChAdOx1-S [recombinant]) vaccine against COVID-19 developed by Oxford University and AstraZeneca: Interim guidance

WHO Team
Immunization, Vaccines and Biologicals (IVB), WHO Headquarters (HQ)
Number of pages
52
Reference numbers
WHO Reference Number: WHO/2019-nCoV/vaccines/SAGE_recommendation/AZD1222/background/2021.1
Copyright